Biblio Discovery — Demo Discovery Service

4 hasil untuk "Jaganathan, Devi"

Menampilkan 1–4 · 1,05 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Emerging Concepts in Defective Macrophage Phagocytosis in Cystic Fibrosis

    Jaganathan, Devi; Bruscia, Emanuela M.; Kopp, Benjamin T.

    Int J Mol Sci · 2022 · Inggris · PubMed Central

    Cystic fibrosis (CF) is caused by mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Chronic inflammation and decline in lung function are major reasons for morbidity in CF. Mutant CFTR expressed in phagocytic cells such as macrophages contributes to persistent…

  2. Artikel Jurnal Teks lengkap

    Impact of Elexacaftor-Tezacaftor-Ivacaftor on Bacterial Colonization and Inflammatory Responses in Cystic Fibrosis

    Sheikh, Shahid; Britt, Rodney D.; Ryan-Wenger, Nancy A. dkk.

    Pediatr Pulmonol · 2022 · Inggris · PubMed Central

    BACKGROUND: Cystic fibrosis (CF) is a multisystem disease with progressive deterioration. Recently, CF transmembrane conductance regulator (CFTR) modulator therapies were introduced that repair underlying protein defects. Objective of this study was to determine the impact of…

  3. Artikel Jurnal Teks lengkap

    Structure, function, and inhibition of adenylosuccinate lyase (ADSL) from Mycobacterium tuberculosis

    Singh, Vigyasa; Jaganathan, Devi; Corro, Jamie dkk.

    ACS Infect Dis · 2025 · Inggris · PubMed Central

    Adenylosuccinate lyase (ADSL), encoded by the purB gene, is an essential enzyme in the purine biosynthesis pathway of Mycobacterium tuberculosis (Mtb), making it a promising target for antimicrobial drug development. Here, we report the expression, purification, kinetic characterization…

  4. Artikel Jurnal Teks lengkap

    Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor

    Zhang, Shuzhong; Shrestha, Chandra L.; Robledo-Avila, Frank dkk.

    Eur Respir J · 2023 · Inggris · PubMed Central

    BACKGROUND: Abnormal macrophage function caused by dysfunctional cystic fibrosis transmembrane conductance regulator (CFTR) is a critical contributor to chronic airway infections and inflammation in people with cystic fibrosis (PWCF). Elexacaftor/tezacaftor/ivacaftor (ETI) is a new CFTR modulator…